What the studies show
No human dosing study exists. A molecule that drives new synapse formation this potently has an obvious theoretical concern — uncontrolled growth signalling — that has never been evaluated in people.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
In context
Dihexa is a small synthetic molecule derived from angiotensin IV, studied for its striking ability to promote new synapse formation in rodents and its potential in memory and Parkinson's models. It is not a true peptide and, more importantly, has never been tested in a controlled human trial. It is sold as a 'nootropic' research chemical with no human evidence and no safety data.
Dihexa is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Dihexa proven to cause safety in humans?
What studies are behind the grade?
Is Dihexa approved for this?
Other outcomes for Dihexa
- DCognition / synapse formation0 controlled
Written and maintained by LYO Research — how pages are written and checked. Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →